KiOmed Pharma and Hansoh Pharma Announce License Agreement for KiOmedinevsOne in China's Mainland, Macau and Taiwan - Press Release
- KiOmedinevsOne is a non-animal sourced chitosan injection that has been launched in Europe for the treatment of knee osteoarthritis. - KiOmed Pharma
Source: wiredprnews.com